E
Entero Healthcare Solutions Ltd
NSE:ENTERO
Entero Healthcare Solutions Ltd
NSE:ENTERO
Price:
1 131.6
INR
-1.08%
Market Cap:
₹49.2B
Relative Value
There is not enough data to reliably calculate the relative value of ENTERO.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ENTERO
Relative Value
Base Case
Not Available
E
Multiples Across Competitors
ENTERO Competitors Multiples
Entero Healthcare Solutions Ltd Competitors
Entero Healthcare Solutions Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
E
|
Entero Healthcare Solutions Ltd
NSE:ENTERO
|
49.1B INR | 0 | 0 | 0 | 0 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
106.1B USD | 0.3 | 26.3 | 18.5 | 20.8 | |
| US |
|
Cencora Inc
NYSE:COR
|
70.7B USD | 0.2 | 45.4 | 15.3 | 19.7 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.3B USD | 0.2 | 45.3 | 15.3 | 19.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
52.3B USD | 0.2 | 32.7 | 16 | 20.9 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
36.3B AUD | 6 | 68.5 | 51.5 | 51.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.4B CNY | 1.5 | 17.1 | 13.2 | 13.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 0.7 | 22.3 | 10.9 | 15.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.7B HKD | 0.1 | 8.6 | 1.6 | 2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
